Zabi don melanoma da cutar huhu
Wadatacce
Opdivo magani ne na rigakafi wanda ake amfani dashi don magance nau'ikan cututtukan oncological iri biyu, melanoma, wanda shine mummunan cutar kansa, da cutar huhu.
Wannan magani yana taimakawa wajen ƙarfafa garkuwar jiki, inganta haɓakar jiki game da ƙwayoyin kansar, yana gabatar da ƙananan sakamako masu illa fiye da hanyoyin maganin gargajiya kamar chemotherapy ko radiation radiation.
Abun aiki a cikin Opdivo shine Nivolumab kuma an samar dashi ta hanyar dakunan gwaje-gwaje na Bristol-Myers Squibb. Gabaɗaya, ba a yawan siyan wannan magani, tunda ana siyan shi kuma ana amfani da shi a asibitocin kansu, duk da haka ana iya siyan shi a cikin shagunan sayar da magani tare da mafi tsananin nuni na likita.
Farashi
A cikin Brazil, ƙimar Opdivo ta kashe, a matsakaita, dubu 4 na vial 40mg / 4ml, ko reais dubu 10 don vial 100mg / 10ml, wanda zai iya bambanta gwargwadon kantin da yake sayarwa.
Wanene zai iya amfani
Nivolumab an nuna shi don maganin ciwon daji na huhu wanda ya bazu kuma ba a sami nasarar magance shi ba tare da cutar sankara. Bugu da ƙari, ana iya amfani da shi don magance melanoma a cikin yanayin inda ciwon daji ya bazu sosai kuma ba za a iya cire shi da tiyata ba.
Yadda ake amfani da shi
Dole ne likita ya ayyana yanayin amfani da wannan magani ya danganta da kowane yanayi, nau'in ciwon daji, ban da nauyin jikin kowane mutum, amma galibi ana gudanar da Opdivo a asibiti kai tsaye cikin jijiya, a cikin ruwan gishiri ko glucose , a cikin zaman minti 60 a rana.
Gabaɗaya, shawarar da aka ba da shawarar ita ce MG 3 na Nivolumab a kowace kilogram na nauyinku, kowane mako 2, wanda zai iya bambanta dangane da alamar likita.
Abubuwan da ba'a so ba
Babban illolin Opdivo sun hada da tari mai dorewa, ciwon kirji, wahalar numfashi, gudawa, kujerun jini, ciwon ciki, launin rawaya ko idanu, tashin zuciya, amai, yawan gajiya, ƙaiƙayi da jan fata, zazzabi, ciwon kai. Ciwon kai, tsoka zafi da hangen nesa.
Duk wani sabon alamun cutar da aka lura ya kamata a sanar da shi ga likita kuma a sa masa ido, kamar yadda mummunan sakamako tare da Nivolumab na iya faruwa a kowane lokaci yayin ko bayan jiyya, kuma ya kamata a sanya ido kan marasa lafiya a ci gaba yayin amfani da su don kauce wa ci gaban matsalolin da ke iya faruwa. pneumonitis, colitis, hepatitis ko nephritis, misali.
Wanda ba zai iya dauka ba
Wannan maganin yana da alaƙa a cikin yanayin rashin lafiyan shan magani ko ga duk wani mai kwazo a cikin tsarin.
Babu sauran takaddama game da wannan magani da ANVISA ke bayyana, duk da haka, ya kamata a yi amfani dashi cikin hankali ga mata masu ciki da marasa lafiya masu cutar pneumonitis, colitis, hepatitis, cututtukan endocrin, nephritis, matsalolin koda ko encephalitis.